Results 161 to 170 of about 27,956 (253)

Localized scleroderma is an autoimmune disorder

Objectives. There have been many studies suggesting that localized scleroderma has a strong autoimmune background, although the lesions are usually limited to the skin and subcutaneous tissue.
Takehara, Kazuhiko, Sato, Shinichi
core  

Predictor factors of successful treatment response in interstitial lung disease-related systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Danasasmita GW, Wibowo SAK, Rumende CM, Rizka A, Sumariyono S, Ariane A, Shatri H, Singh G.   +7 more
europepmc   +1 more source

Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care. [PDF]

J Scleroderma Relat Disord
Savoie MB, Logeman JL, Castelino FV.
europepmc   +1 more source

Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs. [PDF]

J Scleroderma Relat Disord
Mahmood M, Hughes M, McMahan Z, Shapiro L.   +3 more
europepmc   +1 more source

Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Valenzuela A, Chung L, Pauling JD, Domsic R, Saketkoo L, Fligelstone K, Russell AM, Khanna D, Frech T, Ross L, Nikpour M, Denton C, Baron M.   +12 more
europepmc   +1 more source

Analysis of the Col1a1 Collagen Gene in Patients with Limited Scleroderma

International Journal of Psychosocial Rehabilitation, 2020
Munojat Kulmanova, Otabek Muydinov, Dilshod Inoyatov, Makhsuma Sultonova, Tolibboy Mustanov   +4 more
openaire   +1 more source

Cross-cultural adaptation, reliability and construct validity of the Arabic Scleroderma Assessment Questionnaire in Egyptian patients with systemic sclerosis. [PDF]

Clin Rheumatol
El-Farra OA, Hassanien M, Ibrahim AM, Ghazy WM, Abdelaleem EA, Aboeladl NA, Mohannad N, Abdelgalil KAA, Maghraby GG, Ahmed AK, Elsaadany H, Khalil SA, Nasef SI, Tharwat S, Hammam O, Hafez SM, Hammam N, Gheita TA.   +17 more
europepmc   +1 more source

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort. [PDF]

J Scleroderma Relat Disord
Foeldvari I, Torok K, Kasapcopur O, Adrovic A, Feldman B, Sztajnbok F, Terreri MT, Sakamoto AP, Johnson S, Anton J, Stanevicha V, Khan A, Schonenberg-Meinema D, Al-Abadi E, Alexeeva E, Katsicas M, Sawhney S, Smith V, Appenzeller S, Avcin T, Kostik M, Lehman T, Malcova H, Marrani E, Pain CE, Patwardhan A, Sifuentes-Giraldo WA, Vasquez-Canizares N, Costa-Reis P, Janarthanan M, Moll M, Nemcova D, Santos MJ, Abu Al-Saoud S, Battagliotti C, Berntson L, Bica B, Brunner J, Eleftheriou D, Harel L, Horneff G, Kaiser D, Kallinich T, Lazarevic D, Minden K, Nielsen S, Nuruzzaman F, Hetlevik SO, Uziel Y, Klotsche J.   +49 more
europepmc   +1 more source

Cytometry-based blood immune cell markers associated with clinical outcomes in systemic sclerosis: protocol for a systematic review. [PDF]

BMJ Open
Souffez M, Dumontet E, Lecureur V, Lescoat A, Ferrant J.   +4 more
europepmc   +1 more source

Clearance of corticosteroids in pediatric patients with active eosinophilic esophagitis: Faster than expected

Pediatric Allergy and Immunology, Volume 37, Issue 6, June 2026.
Pamela Fernanda Alves Barbosa, Marcelo Tatit Sapienza, Antonio Carlos Pastorino, Ariana Campos Yang, Glauce Hiromi Yonamine, Mayra de Barros Dorna, Ana Paula Beltran Moschione Castro   +6 more
wiley   +1 more source